IEC Letter No. SSCASRH/IEC/001/21
CTRI Regd. No. CTRI/2021/08/035908
Aim of the Study
To find out the efficacy of NF1 and NF3 in the treatment of COVID19 patients.
Objective of the Study
- To assess subjective and objective parameters of COVID19 patients on NF1 and NF3 blind medicine in the treatment procedure.
- To evaluate the efficacy of double blind medicines.
- To establish Ayurveda/Siddha medicine for the treatment of COVID19 patients.
Research started: 26/08/2021
End of Research: 13/09/2021
